The latest announcement is out from Atara Biotherapeutics ( (ATRA) ).
Atara Biotherapeutics has appointed Eric Hyllengren as Chief Operating Officer, in addition to his role as Chief Financial Officer, highlighting his extensive experience at Amgen and within Atara since 2018. With a background in finance from Notre Dame and an MBA from Kellogg, Hyllengren’s promotion comes without any linked arrangements, family ties, or related transactions, now earning a $520,000 annual salary.
For a thorough assessment of ATRA stock, go to TipRanks’ Stock Analysis page.
